Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kristen Georgiou"'
Autor:
Marnie Winter, Zhen Cai, Katharina Winkler, Kristen Georgiou, Daniel Inglis, Tina Lavranos, Meysam Rezaei, Majid Warkiani, Benjamin Thierry
Publikováno v:
MethodsX, Vol 6, Iss , Pp 1512-1520 (2019)
The detection and molecular analysis of circulating tumour cells (CTCs) potentially provides a significant insight to the characterisation of disease, stage of progression and therapeutic options for cancer patients. Following on from the protocol by
Externí odkaz:
https://doaj.org/article/7627608e95564ab4949fbfd4073c062a
Autor:
Daniel J. Inglis, Katharina Winkler, Tina C. Lavranos, Marnie Winter, Zhen Cai, Kristen Georgiou, Meysam Rezaei, Benjamin Thierry, Majid Ebrahimi Warkiani
Publikováno v:
MethodsX, Vol 6, Iss, Pp 1512-1520 (2019)
The detection and molecular analysis of circulating tumour cells (CTCs) potentially provides a significant insight to the characterisation of disease, stage of progression and therapeutic options for cancer patients. Following on from the protocol by
Autor:
Jeganath Krishnan, Angela H. Deakin, Christopher John Wilson, Kristen Georgiou, Annika Theodoulou, Ezekiel Oburu
Publikováno v:
Journal of Orthopaedics. 15:328-332
Purpose This aim of this study was to evaluate the rate of surgical site infection (SSI) in patients undergoing Total Knee Arthroplasty (TKA), to improve our understanding of the associations between infection rate and obesity. Methods Data was revie
Publikováno v:
Australasian Medical Journal, Vol 9, Iss 9, Pp 297-307 (2016)
This study investigates the relative efficacy of the Flinders chronic condition self-management program versus treatment as usual in obese patients with hip or knee osteoarthritis on a knee/hip joint replacement waiting list
Autor:
Ross A. McKinnon, Dorothy M. K. Keefe, Kristen Georgiou, Cory J. Xian, Peter R. C. Howe, Chiaming Fan
Publikováno v:
Journal of Bone and Mineral Metabolism. 34:277-290
The introduction of anthracyclines to adjuvant chemotherapy has increased survival rates among breast cancer patients. Cyclophosphamide, epirubicin and 5-fluorouracil (CEF) combination therapy is now one of the preferred regimens for treating node-po
Publikováno v:
Journal of Cellular Physiology. 230:648-656
Antimetabolite Methotrexate (MTX) is commonly used in childhood oncology. As a dihydrofolate reductase inhibitor it exerts its action through the reduction of cellular folate, thus its intensive use is associated with damage to soft tissues, bone mar
Autor:
Jia Liu, Kristen Georgiou, Damien J. Keating, Yan-Jiang Wang, Ying Sun, Jin Hua Zhong, Khalil Saadipour, Miao Yang, Wei Ping Gai, Xin-Fu Zhou, Ye-Ran Wang, Yoon Lim
Publikováno v:
Journal of Neurochemistry. 127:152-162
Sortilin, a Golgi sorting protein and a member of the VPS10P family, is the co-receptor for proneurotrophins, regulates protein trafficking, targets proteins to lysosomes, and regulates low density lipoprotein metabolism. The aim of this study was to
Autor:
Kristen Georgiou, Ross A. McKinnon, Cory J. Xian, Dorothy M. K. Keefe, Peter R. C. Howe, Chiaming Fan, Howard A. Morris
Purpose: Anthracyclines (including doxorubicin) are still the backbone of commonly used breast cancer chemotherapy regimens. Despite increasing use of doxorubicin and cyclophosphamide (AC) combinations for treating breast cancer, their potential to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3bc4e1b16e7d6c8b6a2ad4790350947
https://hdl.handle.net/11541.2/127001
https://hdl.handle.net/11541.2/127001
Autor:
Kristen Georgiou, Hong Zhou, Cory J. Xian, Bruce K. Foster, Michaela Scherer, Tristan J. King
Publikováno v:
Bone. 50:1223-1233
Cancer chemotherapy often causes significant bone loss, marrow adiposity and haematopoietic defects, yet the underlying mechanisms and recovery potential remain unclear. Wnt/β-catenin signalling is integral to the regulation of osteogenesis, adipoge
Publikováno v:
International Journal of Experimental Pathology. 93:104-114
Cancer chemotherapy disrupts the bone marrow (BM) microenvironment affecting steady-state proliferation, differentiation and maintenance of haematopoietic (HSC) and stromal stem and progenitor cells; yet the underlying mechanisms and recovery potenti